Nei-like DNA glycosylase 2 selectively antagonizes interferon-β expression upon respiratory syncytial virus infection
Journal of Biological Chemistry · 2023-08 · 299 (8) · 105028
DOI: 10.1016/j.jbc.2023.105028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2023-08. Verfasst von Lang Pan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA. Hauptthemen laut MEDLINE: DNA Glycosylases, Interferon-beta, Respiratory Syncytial Virus Infections, Respiratory Syncytial Viruses. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
As part of the antiviral response, cells activate the expressions of type I interferons (IFNs) and proinflammatory mediators to control viral spreading. Viral infections can impact DNA integrity; however, how DNA damage repair coordinates antiviral response remains elusive. Here we report Nei-like DNA glycosylase 2 (NEIL2), a transcription-coupled DNA repair protein, actively recognizes the oxidative DNA substrates induced by respiratory syncytial virus (RSV) infection to set the threshold of IFN-β expression. Our results show that NEIL2 antagonizes nuclear factor κB (NF-κB) acting on the IFN-β promoter early after infection, thus limiting gene expression amplified by type I IFNs. Mice lacking Neil2 are far more susceptible to RSV-induced illness with an exuberant expression of proinflammatory genes and tissue damage, and the administration of NEIL2 protein into the airway corrected these defects. These results suggest a safeguarding function of NEIL2 in controlling IFN-β levels against RSV infection. Due to the short- and long-term side effects of type I IFNs applied in antiviral therapy, NEIL2 may provide an alternative not only for ensuring genome fidelity but also for controlling immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
- Department of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
- Faculty of Medicine, Department of Immunology, University of Debrecen, Debrecen, Hungary.
- Key Laboratory of Molecular Epigenetics of Ministry of Education, School of Life Science, Northeast Normal University, Changchun, Jilin, China.
- Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA. Electronic address: sboldogh@utmb.edu.
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NINDS NIH HHS
- National Natural Science Foundation of China
- National Research Development and Innovation Office
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
- National Institutes of Health
- University of Texas Medical Branch
Zitieren
APA
Pan, L., Xue, Y., Wang, K., Zheng, X., Islam, A., Tapryal, N., Chakraborty, A., Bacsi, A., Ba, X., Hazra, T. K., & Boldogh, I. (2023). Nei-like DNA glycosylase 2 selectively antagonizes interferon-β expression upon respiratory syncytial virus infection. Journal of Biological Chemistry, 299(8), 105028. https://doi.org/10.1016/j.jbc.2023.105028
Vancouver
Pan L, Xue Y, Wang K, Zheng X, Islam A, Tapryal N, et al. Nei-like DNA glycosylase 2 selectively antagonizes interferon-β expression upon respiratory syncytial virus infection. Journal of Biological Chemistry. 2023;299(8):105028. doi:10.1016/j.jbc.2023.105028
BibTeX
@article{Pan2023,
author = {Pan, Lang and Xue, Yaoyao and Wang, Ke and Zheng, Xu and Islam, Azharul and Tapryal, Nisha and Chakraborty, Anirban and Bacsi, Attila and Ba, Xueqing and Hazra, Tapas K and Boldogh, Istvan},
title = {Nei-like DNA glycosylase 2 selectively antagonizes interferon-β expression upon respiratory syncytial virus infection},
journal = {Journal of Biological Chemistry},
year = {2023},
volume = {299},
number = {8},
pages = {105028},
doi = {10.1016/j.jbc.2023.105028}
}
EUVIMED